Primary antibiotic resistance in Helicobacter pylori strains isolated in northern and central Italy

被引:101
作者
Zullo, A.
Perna, F.
Hassan, C.
Ricci, C.
Saracino, I.
Morini, S.
Vaira, D.
机构
[1] Osped Nuovo Regina Margherita, I-00153 Rome, Italy
[2] Univ Bologna, Dept Internal Med & Gastroenterol, I-40126 Bologna, Italy
[3] Univ Brescia, Gastroenterol Unit, Brescia, Italy
关键词
D O I
10.1111/j.1365-2036.2007.03331.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Helicobacter pylori resistance to antibiotics is increasing worldwide, and it reduces the efficacy of therapy. Aim To assess current primary antibiotic resistance in H. pylori strains isolated in Italy. Methods Between June 2004 and June 2006, H. pylori strains were isolated consecutively in the two participating centres (Bologna, northern Italy; Rome, central Italy) from patients never previously treated for the infection. Isolated strains were tested for primary clarithromycin, metronidazole and levofloxacin resistance using as break point the minimal inhibitory concentration >= 1, >= 8 and >= 1 mg/L for the three antibiotics, respectively. Results Overall, 255 H. pylori strains were evaluated. The resistance rate was 16.9% for clarithromycin, 29.4% for metronidazole and 19.1% for levofloxacin. Clarithromycin resistance was significantly higher in non-ulcer dyspepsia than in peptic ulcer patients (19.1% vs. 0%, P = 0.02), metronidazole resistance was higher in foreign than Italian patients (50% vs. 22.9%, P = 0.0004) and levofloxacin resistance was higher in old than younger patients (28.4% vs. 14.4%, P = 0.048). Levofloxacin resistance was also more frequent in those strains with either clarithromycin or metronidazole resistance. Conclusion A very high rate of primary resistance towards the tested antibiotics was detected in our study.
引用
收藏
页码:1429 / 1434
页数:6
相关论文
共 40 条
[1]  
[Anonymous], GUT
[2]   Prevalence and mechanisms of resistance to fluoroquinolones in Helicobacter pylori strains from patients living in Belgium [J].
Bogaerts, Pierre ;
Berhin, Catherine ;
Nizet, Henri ;
Glupczynski, Youri .
HELICOBACTER, 2006, 11 (05) :441-445
[3]   Efficacy of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection [J].
Cammarota, G ;
Cianci, R ;
Cannizzaro, O ;
Cuoco, L ;
Pirozzi, G ;
Gasbarrini, A ;
Armuzzi, A ;
Zocco, MA ;
Santarelli, L ;
Arancio, F ;
Gasbarrini, G .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (10) :1339-1343
[4]   High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection [J].
Cammarota, G ;
Martino, A ;
Pirozzi, G ;
Cianci, R ;
Branca, G ;
Nista, EC ;
Cazzato, A ;
Cannizzaro, O ;
Miele, L ;
Grieco, A ;
Gasbarrini, A ;
Gasbarrini, G .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (07) :789-795
[5]   Update on fluoroquinolone resistance in Helicobacter pylori:: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility [J].
Cattoir, Vincent ;
Nectoux, Juliette ;
Lascols, Christine ;
Deforges, Lionel ;
Delchier, Jean-Charles ;
Megraud, Francis ;
Soussy, Claude-James ;
Cambau, Emmanuelle .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 (04) :389-396
[6]   New once-daily, highly effective rescue triple therapy after multiple Helicobacter pylori treatment failures:: a pilot study [J].
Coelho, LGV ;
Moretzsohn, LD ;
Vieira, WLS ;
Gallo, MA ;
Passos, MCF ;
Cindr, JM ;
Cerqueira, MC ;
Vitiello, L ;
Ribeiro, ML ;
Mendonça, S ;
Pedrazzoli, J ;
Castro, LP .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 (06) :783-787
[7]   Clarithromycin-resistant genotypes and eradication of Helicobacter pylori [J].
De Francesco, V ;
Margiotta, M ;
Zullo, A ;
Hassan, C ;
Trolani, L ;
Burattini, O ;
Stella, F ;
Di Leo, A ;
Russo, F ;
Marangi, S ;
Monno, R ;
Stoppino, V ;
Morini, S ;
Panella, C ;
Ierardi, E .
ANNALS OF INTERNAL MEDICINE, 2006, 144 (02) :94-100
[8]   Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure [J].
De Francesco, V ;
Zullo, A ;
Margiotta, M ;
Marangi, S ;
Burattini, O ;
Berloco, P ;
Russo, F ;
Barone, M ;
Di Leo, A ;
Minenna, MF ;
Stoppino, V ;
Morini, S ;
Panella, C ;
Francavilla, A ;
Ierardi, E .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (04) :407-414
[9]   Prevalence of primary clarithromycin resistance in Helicobacter pylori strains over a 15 year period in Italy [J].
De Francesco, Vincenzo ;
Margiotta, Marcella ;
Zullo, Angelo ;
Hassan, Cesare ;
Giorgio, Floriana ;
Burattini, Osvaldo ;
Stoppino, Giuseppe ;
Cea, Ugo ;
Pace, Antonella ;
Zotti, Mariangela ;
Morini, Sergio ;
Panella, Carmine ;
Ierardi, Enzo .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (04) :783-785
[10]   Improved efficacy of 10-day sequential treatment for Helicobacter pylori eradication in children:: a randomized trial [J].
Francavilla, R ;
Lionetti, E ;
Castellaneta, SP ;
Magistà, AM ;
Boscarelli, G ;
Piscitelli, D ;
Amoruso, A ;
Di Leo, A ;
Miniello, VL ;
Francavilla, A ;
Cavallo, L ;
Ierardi, E .
GASTROENTEROLOGY, 2005, 129 (05) :1414-1419